Synulox LC 24pk

A broad spectrum antibiotic tube formulated for the treatment of bovine mastitis. It has a notably broad spectrum of bactericidal activity against the bacteria commonly isolated from the bovine udder.

The prednisolone in Synulox Lactating Cow has an anti-inflammatory action which helps to reduce the potentially destructive swelling and inflammation associated with mastitis, without affecting the white cell response to infection.

Dosage A course of 3 syringes per affected quarter-one syringe every 12 hours. Administration After milking, clean and disinfect the teat end thoroughly with surgical spirit. Insert the syringe nozzle into the teat orifice and apply gentle and continuous pressure until the suspension is expressed. The treated quarter(s) may be milked out at the next normal milking time, but the milk should be discarded. Combined Therapy for the treatment of bovine mastitis. In the situation where systemic treatment as well as intramammary treatment is necessary, Synulox Ready-To-Use Injection can be administered in combination with Synulox Lactating Cow Intramammary using the following minimum treatment regime.

Milk for human consumption must not be taken from a cow during treatment. With cows milked twice daily, milk for human consumption may only be taken from 60 hours (i.e. at the 5th milking) after the last treatment.

Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 7 days from the last treatment.

With other milking routines, the basis of the veterinary surgeon's advice should be that milk may be taken for human consumption only after the same period from the last treatment (e.g. with three times a day milking and the product administered twice per day, milk for human consumption may only be taken at the 6th milking).

Combined Therapy: When using Synulox LC Intramammary and Synulox RTU in combination, animals must not be slaughtered for human consumption during treatment. Cows may not be slaughtered for human consumption until 42 days after the last treatment. Milk must not be taken for human consumption during treatment. Milk for human consumption may be taken only from cows after 60 hours from the last treatment of Synulox RTU following the minimum dosage regime described in Dosage and Administration.

To know more about this product please click on the link below...

http://www.noahcompendium.co.uk/Pfizer_Limited/Synulox_Lactating_Cow_Intramammary_Suspension/-31102.html